About this project
Glyxine is a repurposing an existing drug that has been reformulated into a nanoemulsion drug delivery system to treat viral diseases including coronaviruses and Influenza.  The nanotechnology drug delivery system can deliver the drug as an inhalant such as the drug delivery of asthma drugs, it can also be delivered via a nebulizer, and as a nasal spray.  Glyxine is ready to go to clinical trials.